← FDA Drug Approvals (Drugs@FDA)

ESCITALOPRAM OXALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2012-09-11

Drug application

FDA Application #

ANDA078604

Application type

Abbreviated New Drug Application (Generic)

Brand name

ESCITALOPRAM OXALATE

Generic name

ESCITALOPRAM

Active ingredients

ESCITALOPRAM OXALATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INVAGEN PHARMS

Manufacturer

Exelan Pharmaceuticals Inc.

First approval

2012-09-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown